Erlotinib Completed Phase 1 Trials for Cancer of Parotid / Malignant Neoplasm of Thyroid / Head and Neck Carcinoma / Parotid Gland Cancer / Thyroid neoplasms malignant / Stage IV Head and Neck Cancer / Melanoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00079053Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00405405Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
NCT00113347Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)